drugset / Trial / NCT01794741

3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis

NCT01794741

Phase 3 Completed 405 enrolled Meda Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a 3 month safety study of Dymista Nasal spray in children aged 4 to 11 years with allergic rhinitis

Timeline

Start
2013-02
Primary completion
2013-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azelastine Small molecule 137 ug Intranasal
Comparator Fluticasone propionate Other / unclassified 50 ug Intranasal

Indications